Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma

Cancer Research

Volumn 59, Issue 4, 1999, Pages 975-981

  Nagaoka, Yoshiko ^a,b   Kabeya, Hidenori ^c   Onuma, Misao ^c   Kasai, Noriyuki ^b   Okada, Kosuke ^d   Aida, Yoko ^a  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d IWATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMINO ACID COMPOSITION; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA POLYMORPHISM; EXON; GENE ISOLATION; IMMUNOREACTIVITY; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SHEEP;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; CATTLE; DISEASE SUSCEPTIBILITY; ENZOOTIC BOVINE LEUKOSIS; GENOTYPE; HLA-DR ANTIGENS; IMMUNIZATION; LEUKEMIA VIRUS, BOVINE; LYMPHOMA; MOLECULAR SEQUENCE DATA; SHEEP;

EID: 0033557558     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Burny, A., Cleuter, Y., Kettmann, R., Mammerickx, M., Marbaix, G., Portetelle, D., van den Broeke, A., Willems, L., and Thomas, R. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer. Adv. Vet. Sci. Comp. Med., 32: 149-170, 1988.
2. Coffin, J. M. Retroviridae: the viruses and their replication. In: B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (eds.), Fields Virology, 2nd ed., Vol. 2, pp. 1767-1847. Philadelphia: Lippincott-Raven, 1996.
3. Sodroski, J. G., Rosen, C. A., and Haseltine, W. A. trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science (Washington DC), 225: 381-385, 1984.
4. Sagata, N., Tsuzuku, K. J., Nagayoshi-Aida, M., Shimizu, F., Imagawa, K., and Ikawa, Y. Identification and some biochemical properties of the major XBL gene product of bovine leukemia virus. Proc. Natl. Acad. Sci. USA, 82: 7879-7883, 1985.
5. Hidaka, M., Inoue, J., Yoshida, M., and Seiki, M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J., 7: 519-523, 1988.
6. Derse, D. trans-acting regulation of bovine leukemia virus mRNA processing. J Virol., 62: 1115-1119, 1988.
7. Djilali, S., Parodi, A-L., Levy, D., and Cockerell, G. L. Development of leukemia and lymphosarcoma induced by bovine leukemia virus in sheep: a hematopathological study. Leukemia (Baltimore), 1: 777-781, 1987.
8. Aida, Y., Miyasaka, M., Okada, K., Onuma, M., Kogure, S., Suzuki, M., Minoprio, P., Levy, D., and Ikawa, Y. Further phenolypic characterization of target cells for bovine leukemia virus experimental infection in sheep. Am. J. Vet. Res., 50: 1946-1951, 1989.
9. + B cells in asymptomatic stage. Virology, 202: 458-465, 1994.
10. Murakami, K., Aida, Y., Kageyama, R., Numakunai, S., Ohshima, K., Okada, K., and Ikawa, Y. Immunopathological study and characterization of the phenotype of transformed cells in sheep with bovine leukemia virus-induced lymphosarcoma. Am. J. Vet. Res., 55: 72-80, 1994.
11. Schwartz, I., and Levy, D. Pathobiology of bovine leukemia virus. Vet. Res. (Paris), 25: 521-536, 1994.
12. Aida, Y., Okada, K., and Amanuma, H. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma. Cancer Res., 53: 429-437, 1993.
13. Jorgensen, J. L., Reay, P. A., Ehrich, E. W., and Davis, M. M. Molecular components of T-cell recognition. Annu. Rev. Immunol., 10: 835-873, 1992.
14. Germain, R. N., and Margulies, D. H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol., 11: 403-450, 1993.
15. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature (Lond.), 329: 506-512, 1987.
16. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. Three-dimensional structure of the human class II histocompalibility antigen HLA-DR1. Nature (Lond.), 364: 33-39, 1993.
17. Hammer, J., Takacs, B., and Sinigaglia, F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. I. Exp. Med., 176: 1007-1013, 1992.
18. Sette, A., Sidney, J., Oseroff, C., del Guercio, M. F., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C., and Gray, H. M. HLA DR4w4 binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol., 151: 3163-3170, 1993.
19. Falk, K., Rolzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
20. Rudensky, A. Y., Preston, H. P., Al-Ramadi, B. K., Rothbard, J., and Janeway, C. J. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature (Lond.), 359: 429-431, 1992.
21. Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A., and Strominger, J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (Lond.), 358: 764-768, 1992.
22. Stern, L. J., Brown, I. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (Lond.), 368: 215-221, 1994.
23. Todd, I. A., Acha-Orbea,. H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Stemman, L., and McDevitt, H. O. A molecular basis for MHC class II-associated autoimmunity. Science (Washington DC), 240: 1003-1009, 1988.
24. Zerva, L., Cizman, B., Mehra, N. K., Alahari, S. K., Murali, R., Zmijewski, C. M., Kamoun, M., and Monos, D. S. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J. Exp. Med., 183: 829-836, 1996.
25. Hill, A. V., Allsopp, C. E., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., and Greenwood, B. M. Common West African HLA antigens are associated with protection from severe malaria. Nature (Lond.), 352: 595-600, 1991.
26. Özdemir, E., Kakehi, Y., Nakamura, E., Kinoshita, H., Terachi, T., Okada, Y., and Yoshida, O. HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma. Cancer Res., 57: 742-746, 1997.
27. Wank, R., and Thomssen, C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature (Lond.), 352: 723-725, 1991.
28. Glew, S. S., Stern, P. L., Davidson, J. A., and Dyer, P. A. HLA antigens and cervical carcinoma. Nature (Lond.), 356: 22, 1992.
29. Lee, J. E., Reveille, J. D., Ross, M. I., and Platsoucas, C. D. HLA-DQB1 *0301 association with increased cutaneous melanoma risk. Int. J. Cancer, 59: 510-513, 1994.
30. Lewin, H. A., and Bemoco, D. Evidence for BoLA-linked resistance and susceptibility to subclinical progression of bovine leukemia virus infection. Anim. Genet., 17: 197-207, 1986.
31. Lewin, H. A., Wu, M-C., Stewart, J. A., and Nolan, T. J. Association between BoLA and subclinical bovine leukemia virus infection in a herd of Holstein-Friesian cows. Immunogenetics, 27: 338-344, 1988.
32. Stear, M. J., Dimmock, C. K., Newman, M. J., and Nicholas, F. W. BoLA antigens are associated with increased frequency of persistent lymphocytosis in bovine leukemia virus infected cattle and with increased incidence of antibodies to bovine leukemia virus. Anim. Genet., 19: 151-158, 1988.
33. van Eijk, M. J., Stewart, H. J. A., Beever, J. E., Fernando, R. L., and Lewin, H. A. Development of persistent lymphocytosis in cattle is closely associated with DRB2. Immunogenetics, 37: 64-68, 1992.
34. Xu, A., van Eijk, M. J., Park, C., and Lewin, H. A. Polymorphism in BoLA-DKB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus. J. Immunol., 151: 6977-6985, 1993.
35. Zanolti, M., Poli, G., Ponti, W., Polli, M., Rocchi, M., Bolzani, E., Longeri, M., Russo, S., Lewin, H. A., and van Eijk, M. J. T. Association of BoLA class II haplotypes with subclinical progression of bovine leukemia virus infection in Holstein-Friesian cattle. Anim. Genet., 27: 337-341, 1996.
36. Aida, Y., Kohda, C., Morooka, A., Nakai, Y., Ogimoto, K., Urao, T., and Asahina, M. Cloning of cDNAs and the molecular evolution of a bovine MHC class II DRA gene. Biochem. Biophys. Res. Commun., 204: 195-202, 1994.
37. Nishino, Y., Tajima, S., and Aida, Y. Cattle cDNA clone encoding a new allele of the MHC class II DQA1 gene. Immunogenetics, 42: 306-307, 1995.
38. Morooka, A., Asahina, M., Kohda, C., Tajima, S., Niimi, M., Nishino, Y., Sugiyama, M., and Aida, Y. Nucleotide sequence and the molecular evolution of a new A2 gene in the DQ subregion of the bovine major histocompatibility complex. Biochem. Biophys. Res. Commun., 212: 110-117, 1995.
39. Aida, Y., Niimi, M., Asahina, M., Okada, K., Nakai, Y., and Ogimoto, K. Identification of a new bovine MHC class II DRB allele by nucleotide sequencing and an analysis of phylogenetk relationships. Biochem. Biophys. Res. Commun., 209: 981-988; 1995.
40. Dikiniene, N., and Aida, Y. Cattle cDNA clones encoding MHC class II DQB1 and DQB2 genes. Immunogenetics, 42: 75, 1995.
41. Gatei, M. H., Naif, H. M., Kumar, S., Boyle, D. B., Daniel, R. C., Good, M. F., and Lavin, M. F. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70. J. Virol., 67: 1803-1810, 1993.
42. Callebaut, I., Voneche, V., Mager, A., Furniere, O., Krchnak, V., Merza, M., Zavada, J., Mammerickx, M., Bumy, A., and Portetelle, D. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J. Virol., 67: 5321-5327, 1993.
43. Miyasaka, M., and Trnka, Z. Sheep as an experimental model for immunology: immunological techniques in vitro and in vivo. In: I. Lefkovits and B. Pernis (eds.), Immunologkal Methods, Vol. 3. pp. 403-422. New York: Academic Press, Inc., 1985.
44. Hughes, S. H., Shank, P. R., Spector, D. H., Kung, H-J., Bishop, J. M., Varmus, H. E., Vogt, P. K., and Breitman, M. L. Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell. 15: 1397-1410, 1978.
45. McKnight, G. S. The induction of ovalbumin and conalbumin mRNA by estrogen and progesterone in chick oviduct explant cultures. Cell, 14: 403-413, 1978.
46. van Eijk, M. J., Stewart-Haynes, J. A., and Lewin, H. A. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet., 23: 483-496, 1992.
47. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74: 5463-5467, 1977.
48. Devereux, I., Haeberli, P., and Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12: 387-395, 1984.
49. Kabeya, H., Ohashi, K., Ohishi, K., Sugimoto, C., Amanuma, H., and Onuma, M. An effective peptide vaccine to eliminate bovine leukemia virus (BLV) infected cells in carrier sheep. Vaccine, 14: 1118-1122, 1996.
50. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory, 1989.
51. Inabe, K., Ikuta, K., and Aida, Y. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology. 245: 53-64, 1998.
52. Tajima, S., Ikawa, Y., and Aida, Y. Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development. J. Virol., 72: 7569-7576, 1998.
53. Schwaiger, F. W., Weyers, E., Buitkamp, J., Ede, A. J., Crawford, A., and Epplen, J. T. Interdependent MHC-DRB exon-plus-intron evolution in artiodactyls. Mol. Biol. Evol., 11: 239-249, 1994.
54. Ballingall, K. T., Wright, H., Redmond, J., Dutia, B. M., Hopkins, J., Lang, J., Deverson, E. V., Howard, J. C., Puri, N., and Haig, D. Expression and characterization of ovine major histocompatibility complex class II (OLA-DK) genes. Anim. Genet., 23: 347-359, 1992.
55. Ballingall, K. T., Dutia, B. M., Hopkins, J., and Wright, H. Analysis of the fine specificities of sheep major histocompatibility complex class II-specific monoclonal antibodies using mouse L-cell transfectants. Anim. Genet., 26: 79-84, 1995.
56. Fu, X. T., Bono, C. P., Woulfe, S. L., Swearingen, C., Summers, N. L., Sinigaglia, F., Seite, A., Schwarte, B. D., and Karr, R. W. Pocket 4 of the HLA-DR(α,β 1*0401) molecule is a major determinant of T cell recognition of peptide. J. Exp. Med., 181: 915-926, 1995.
57. Richeldi, L., Sorrentino, R., and Saltini, C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science (Washington DC), 262: 242-244, 1993.
58. Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., Nagy, Z. A., and Sinigaglia, F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med., 181: 1847-1855, 1995.
59. Wank, R., Schendel, D. J., and Thomssen, C. HLA antigens and cervical carcinoma. Nature (Lond.), 356: 22-23, 1992.
60. Han, R., Breitburd, F., Marche, P. N., and Orth, G. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature (Lond.), 356: 66-68, 1992.
61. zur Hausen, H. Viruses in human cancers. Science (Washington DC), 254: 1167-1173, 1991.
62. Tajima, S., Zhuang, W. Z., Kato, M. V., Okada, K., Ikawa, Y., and Aida, Y. Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma. Virology, 243: 235-246, 1998.
63. Rukstalis, D. B., Bubley, G. J., Donahue, J. P., Richie, J. P., Seidman, J. G., and DeWolf, W. C. Regional loss of chromosome 6 in two urological malignancies. Cancer Res., 49: 5087-5090, 1989.
64. Manns, A., Hanchard, B., Morgan, O. S., Wilks, R., Cranston, B., Nam, J. M., Blank, M., Kuwayama, M., Yashiki, S., Fujiyoshi, T., Blattner, W., and Sonoda, S. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population. J. Natl. Cancer Inst., 90: 617-622, 1998.
65. r 32.000 membrane glycoproleins that are serine phosphorytated specifically in bovine leukemia virus-induced lymphosarcoma cells. Cancer Res., 52: 6463-6470, 1992.